Clinical Trials Logo

Clinical Trial Summary

A multicenter, parallel, open, non-inferior randomized controlled trial was conducted to compare the effectiveness and safety of phacotrabeculectomy and phacogoniotomy in the treatment of advanced primary angle closure glaucoma, so as to provide a better surgical alternative.


Clinical Trial Description

Glaucoma is the leading cause of irreversible blindness worldwide, and primary angle closure glaucoma (PACG) accounted for the majority particularly in Asia and China. The preferred treatment method is anti-glaucoma surgery-trabeculectomy (Trab) combined with lens extraction. Phacotrabeculectomy has become the first-line choice of anti-glaucoma suregery in the treatment of advanced PACG. However, it was not an ideal method due to the bleb-related complications and troublesome postoperative nursing, as well as the difficulty for surgeons, caused by trabeculectomy. However, recent studies revealed that the phacoemulsification with intraocular lens implantation (PEI) combined with goniosynechialysis (GSL) has achieved efficacy in the treatment of PACG. With the advent of minimally invasive glaucoma surgeries (MIGS), there is an increasing number studies indicating the MIGS performed great efficacy in the treatment of primary open angle glaucoma. While,there were a few small-sampled retrospective studies which showed therapeutic effects in PACG. The GSL plus goniotomy (GT) could achieve great efficacy in lowering the intraocular pressure of PACG patients. However, there is still a lack of high quality and high-level randomized controlled trials. Therefore, this study intends to conduct a multicenter, parallel, open, non-inferior randomized controlled trial to compare the effectiveness and safety of PEI+ Trab and PEI+GSL+GT in the treatment of advanced PACG, so as to provide a better surgical treatment for PACG. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04878458
Study type Interventional
Source Sun Yat-sen University
Contact
Status Active, not recruiting
Phase N/A
Start date May 31, 2021
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT03187821 - Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure N/A
Active, not recruiting NCT00153699 - Relationship Between Topiramate Use and Ocular Angle Status Phase 4
Completed NCT04683055 - Phaco-Trabeculotomy Vs Phaco-Trabeculectomy N/A
Recruiting NCT02613013 - Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure N/A
Recruiting NCT04602923 - Keratometric Change After XEN, Trabeculectomy and Tube Shunts N/A
Completed NCT06143943 - Anterior Segment Anatomic Parameters for Risk Profiling of Primary Angle-closure Glaucoma
Terminated NCT01151904 - Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients Phase 4
Recruiting NCT05251792 - Macular Pigment Optical Density in Primary Angle-closure Disease
Recruiting NCT02955641 - Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy N/A
Not yet recruiting NCT05593354 - MicroPulse TLT - UK Study
Completed NCT02376725 - Comparing Phaco/IOL Versus Phaco/IOL + Goniosynechialysis in Subjects With PACG N/A
Active, not recruiting NCT00567788 - Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study N/A
Recruiting NCT03323138 - Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma N/A
Recruiting NCT04703712 - Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy N/A
Not yet recruiting NCT02964676 - Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure Glaucoma N/A
Recruiting NCT02959242 - Dresden Glaucoma and Treatment Study (DGTS)
Completed NCT01298635 - Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG) N/A
Completed NCT00051181 - A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma Phase 3
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Recruiting NCT05332665 - AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification